Showing 1 - 12 results of 12 for search 'Agnieszka Jura-Półtorak', query time: 0.04s Refine Results
  1. 1
    Usefulness of Proguanylin, Pentraxin 3 and S100A12 Serum Concentrations in Diagnosis and Monitoring the Disease Activity in Crohn’s Disease

    Usefulness of Proguanylin, Pentraxin 3 and S100A12 Serum Concentrations in Diagnosis and Monitoring the Disease Activity in Crohn’s Disease by Aleksandra Kałużna, Agnieszka Jura-Półtorak, Alicja Derkacz, Krystyna Olczyk, Katarzyna Komosinska-Vassev

    Published 2023-09-01
    Get full text
    Article
  2. 2
    The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity

    The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism P... by Katarzyna Komosinska-Vassev, Olga Gala, Krystyna Olczyk, Agnieszka Jura-Półtorak, Paweł Olczyk

    Published 2020-09-01
    Get full text
    Article
  3. 3
    Circulating Profile of ECM-Related Proteins as Diagnostic Markers in Inflammatory Bowel Diseases

    Circulating Profile of ECM-Related Proteins as Diagnostic Markers in Inflammatory Bowel Diseases by Katarzyna Komosinska-Vassev, Aleksandra Kałużna, Agnieszka Jura-Półtorak, Alicja Derkacz, Krystyna Olczyk

    Published 2022-09-01
    Get full text
    Article
  4. 4
    The Diagnostic Usefulness of Circulating Profile of Extracellular Matrix Components: Sulfated Glycosaminoglycans (sGAG), Hyaluronan (HA) and Extracellular Part of Syndecan-1 (sCD138) in Patients with Crohn’s Disease and Ulcerative Colitis

    The Diagnostic Usefulness of Circulating Profile of Extracellular Matrix Components: Sulfated Glycosaminoglycans (sGAG), Hyaluronan (HA) and Extracellular Part of Syndecan-1 (sCD13... by Alicja Derkacz, Paweł Olczyk, Agnieszka Jura-Półtorak, Krystyna Olczyk, Katarzyna Komosinska-Vassev

    Published 2021-04-01
    Get full text
    Article
  5. 5
    Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis

    Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis by Anna Szeremeta, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, Krystyna Olczyk, Katarzyna Komosińska-Vassev

    Published 2023-08-01
    Get full text
    Article
  6. 6
    Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors

    Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors by Agnieszka Jura-Półtorak, Anna Szeremeta, Krystyna Olczyk, Aleksandra Zoń-Giebel, Katarzyna Komosińska-Vassev

    Published 2021-06-01
    Get full text
    Article
  7. 7
    TNF-α Inhibitors in Combination with MTX Reduce Circulating Levels of Heparan Sulfate/Heparin and Endothelial Dysfunction Biomarkers (sVCAM-1, MCP-1, MMP-9 and ADMA) in Women with Rheumatoid Arthritis

    TNF-α Inhibitors in Combination with MTX Reduce Circulating Levels of Heparan Sulfate/Heparin and Endothelial Dysfunction Biomarkers (sVCAM-1, MCP-1, MMP-9 and ADMA) in Women with... by Anna Szeremeta, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, Krystyna Olczyk, Katarzyna Komosińska-Vassev

    Published 2022-07-01
    Get full text
    Article
  8. 8
    Circulating Profiles of Serum Proguanylin, S100A12 Protein and Pentraxin 3 as Diagnostic Markers of Ulcerative Colitis

    Circulating Profiles of Serum Proguanylin, S100A12 Protein and Pentraxin 3 as Diagnostic Markers of Ulcerative Colitis by Aleksandra Kałużna, Agnieszka Jura-Półtorak, Alicja Derkacz, Julia Jaruszowiec, Krystyna Olczyk, Katarzyna Komosinska-Vassev

    Published 2023-06-01
    Get full text
    Article
  9. 9
    Aggrecan Turnover in Women with Rheumatoid Arthritis Treated with TNF-α Inhibitors

    Aggrecan Turnover in Women with Rheumatoid Arthritis Treated with TNF-α Inhibitors by Anna Szeremeta, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, Magdalena Kopeć-Mędrek, Eugeniusz Józef Kucharz, Krystyna Olczyk

    Published 2020-05-01
    Get full text
    Article
  10. 10
    Plasma and Urine Levels of Glycosaminoglycans in Patients with Systemic Sclerosis and Their Relationship to Selected Interleukins and Marker of Early Kidney Injury

    Plasma and Urine Levels of Glycosaminoglycans in Patients with Systemic Sclerosis and Their Relationship to Selected Interleukins and Marker of Early Kidney Injury by Kornelia Kuźnik-Trocha, Katarzyna Winsz-Szczotka, Katarzyna Komosińska-Vassev, Agnieszka Jura-Półtorak, Adrian Miara, Przemysław Kotyla, Krystyna Olczyk

    Published 2022-10-01
    Get full text
    Article
  11. 11
    Effects of a 15-month anti-TNF-α treatment on plasma levels of glycosaminoglycans in women with rheumatoid arthritis

    Effects of a 15-month anti-TNF-α treatment on plasma levels of glycosaminoglycans in women with rheumatoid arthritis by Anna Szeremeta, Agnieszka Jura-Półtorak, Ewa Maria Koźma, Andrzej Głowacki, Eugeniusz Józef Kucharz, Magdalena Kopeć-Mędrek, Krystyna Olczyk

    Published 2018-09-01
    Get full text
    Article
  12. 12
    Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir

    Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir by Paweł Olczyk, Robert Koprowski, Katarzyna Komosinska-Vassev, Agnieszka Jura-Półtorak, Katarzyna Winsz-Szczotka, Kornelia Kuźnik-Trocha, Łukasz Mencner, Alicja Telega, Diana Ivanova, Krystyna Olczyk

    Published 2017-07-01
    Get full text
    Article

Search Tools: